Skip to content
Teethgrinder – Lifestyle
Author:
24/7 Market News and NeOnc Technology
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier
September 22, 2026
NeOnc Charting New Nasal Route to Treating Brain Cancer
September 21, 2026
NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates
September 17, 2026
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
September 16, 2026
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
September 9, 2026
NeOnc Phase 2 Data Shows Promise for Glioma Treatment
September 8, 2026
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
August 18, 2026
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results
August 17, 2026
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
August 13, 2026
NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears
August 10, 2026
1
2
Next Page
→